日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細

  Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution

Vogel, V., Lochmann, D., Weyermann, J., Mayer, G., Tziatzios, C., van den Broek, J. A., Haase, W., Wouters, D., Schubert, U. S., Kreuter, J., Zimmer, A., & Schubert, D. (2005). Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution. Journal of Controlled Release, 103(1), 99-111. doi:10.1016/j.jconrel.2004.11.029.

Item is

基本情報

表示: 非表示:
資料種別: 学術論文

ファイル

表示: ファイル

関連URL

表示:

作成者

表示:
非表示:
 作成者:
Vogel, Vitali1, 著者
Lochmann, Dirk2, 著者
Weyermann, Jörg2, 著者
Mayer, Gottfried1, 著者
Tziatzios, Christos1, 著者
van den Broek, Jacomina A.1, 著者
Haase, Winfried3, 著者           
Wouters, Daan4, 著者
Schubert, Ulrich S.4, 著者
Kreuter, Jörg2, 著者
Zimmer, Andreas5, 著者
Schubert, Dieter1, 著者
所属:
1Institut für Biophysik, Johann Wolfgang Goethe-Universität, 60590 Frankfurt am Main, Germany, ou_persistent22              
2Institut für Pharmazeutische Technologie, Johann Wolfgang Goethe-Universität, 60439 Frankfurt am Main, Germany, ou_persistent22              
3Department of Structural Biology, Max Planck Institute of Biophysics, Max Planck Society, ou_2068291              
4Laboratory of Macromolecular Chemistry and Nanoscience, Eindhoven University of Technology, NL-5600 MB Eindhoven, The Netherlands, ou_persistent22              
5Institut für Pharmazeutische Chemie und Pharmazeutische Technologie, Karl-Franzens-Universität, 8010 Graz, Austria, ou_persistent22              

内容説明

表示:
非表示:
キーワード: Nanoparticles; Phosphorothioates; Protamine; Human serum albumin (HSA); Cellular release
 要旨: Oligodesoxynucleotides (ODNs) or the corresponding phosphorothioates (PTOs) spontaneously form spherical nanoparticles (“proticles”) with protamine in aqueous solutions. The proticles can cross cellular membranes and release the ODNs within the cells. Thus, they represent a potential drug delivery system. The major disadvantages of this system are a lack of stability in salt solutions and its inability to also release PTOs. The present study shows, using PTOs and protamine free base, that these shortcomings can be eliminated by the addition of human serum albumin (HSA) as a third component to the starting mixture. The “ternary” proticles thus obtained contain maximally a few percent of the HSA that was originally present. Nevertheless, they differ from the previously studied “binary” proticles: (1) They are stable in salt solutions for at least several hours. (2) They show a high cellular uptake into murine fibroblasts, and they readily release the PTOs after uptake. The ternary proticles therefore represent a considerable improvement over binary proticles for use as drug delivery systems.

資料詳細

表示:
非表示:
言語: eng - English
 日付: 2004-07-162004-11-222005-01-082005-03-02
 出版の状態: 出版
 ページ: 13
 出版情報: -
 目次: -
 査読: 査読あり
 識別子(DOI, ISBNなど): DOI: 10.1016/j.jconrel.2004.11.029
PMID: 15710504
 学位: -

関連イベント

表示:

訴訟

表示:

Project information

表示:

出版物 1

表示:
非表示:
出版物名: Journal of Controlled Release
種別: 学術雑誌
 著者・編者:
所属:
出版社, 出版地: Amsterdam : Elsevier
ページ: - 巻号: 103 (1) 通巻号: - 開始・終了ページ: 99 - 111 識別子(ISBN, ISSN, DOIなど): ISSN: 0168-3659
CoNE: https://pure.mpg.de/cone/journals/resource/954925484703